Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- Has the market gotten too complacent about these new highs? Jim Cramer told his Mad Money viewers Friday he thinks that might be the case, and next week's game plan will be a difficult road for the bulls.
Cramer said the markets will be ruled by two macro-economic events next week -- the European Central Bank's decision on interest rates on Thursday and the U.S. non-farm payroll numbers on Friday. Whatever stocks may gain earlier in the week can be easily be undone by these two events.
Then there's the Apple (AAPL) - Get Report Worldwide Developers Conference that kicks off on Monday. Cramer said this stock, which he owns for his charitable trust, Action Alerts PLUS, has created 300,000 jobs in the burgeoning app economy and this conference should help buoy the markets.
Then, on Tuesday, Cramer said he'll be watching Dollar General (DG) - Get Report. While he generally likes the dollar group, Cramer said he'd bet on Target (TGT) - Get Report with its 3% yield and its new CEO.
Wednesday brings earnings from Brown-Forman (BFB) and PVH Corp (PVH) - Get Report. Cramer said he'd be a buyer of Forman but would take profits and lock in gains with PVH because the stock has had a nice move higher.
On Thursday, J.M. Smucker (SJM) - Get Report, Ciena (CIEN) - Get Report, Joy Global (JOY) and Zoe's Kitchen (ZOES) will all be reporting. Cramer said he wants to hear Smucker's thoughts on the recent wave of consolidation in the food stocks, but he'd avoid Joy Global. He was also not a fan of Ciena, preferring Cisco Systems (CSCO) - Get Report, but does approve of owning Zoe's over the long term.
Executive Decision: Tom Pike
For his "Executive Decision" segment, Cramer sat down with Tom Pike, CEO of Quintiles Transnational (Q) , the company biotech firms turn to when they need to outsource their clinical trials. Quintiles just posted a 13-cents-a-share earnings beat on an 8.4% rise in revenue.
Pike said it's been an exciting year for Quintiles. He said there has been a ton of money flowing into biotech firms and that means more drugs that need testing and more business for Quintiles.
There's a lot that goes into planning and executing a successful clinical trial, Pike continued -- from planning and developing it to executing it, monitoring it and then analyzing the results. Quintiles' hundreds of doctors and PhD's all help make that process easier.
Quintiles also has a contract with the National Football League to help analyze all the injury data from pro football and make valid recommendations for improvements to the game.
Cramer said investing in biotech stocks often is a hit or miss proposition with the Food and Drug Administration but by owning Quintiles investors can still be apart of the growing industry while avoiding much of the risk.
Old vs. New Tech
In the battle of old tech versus new tech, it looks like old tech has the upper hand, Cramer told viewers. Old tech continues to plod along with slow but steady growth but also strong fundamentals, dividends and stock buybacks.
Nowhere is this more evident than in the recently announced partnership between old tech Microsoft (MSFT) - Get Report and new tech Salesforce.com (CRM) - Get Report, Cramer said. While Salesforce has all but given up its early gains on the news, Microsoft shares continue to head higher as investors realize the new kinder, gentler Microsoft under its new CEO, Satya Nadella, can only help reinvigorate its sleepy stock price.
Compare that to the new-tech disaster that is Splunk (SPLK) - Get Report, the data analytics company that despite a strong quarter still saw its shares down over 16% as investors deemed the company's growth good but not good enough.
Given these two recent examples, it's easy to see why investors are flocking to old tech, Cramer concluded.
In a special interview, Cramer sat down with Olympic gold-medal snowboarder Sage Kotsenburg to discuss his career and his diversified sponsorship portfolio.
Kotsenburg said all athletes aspire to an honor he just received, being on the face of the iconic Wheaties cereal box by General Mills (GIS) - Get Report. Some of Kotsenburg's other sponsors include Monster Beverage (MNST) - Get Report and Nike (NKE) - Get Report, an Action Alerts PLUS holding. Kotsenburg said that in all three cases, these are products that he's used for years and it was easy to partner with them.
But another of Kotsenburg's sponsors is adventure camera maker GoPro, which recently filed for its IPO. Kotsenburg said that he was one of the first people to start using the company's pocket-sized cameras for snowboarding. Thanks to the videos he's posted, GoPro has been growing in leaps and bounds.
Cramer said Kotsenburg clearly has a diversified sponsorship portfolio of great companies spanning food, beverage, apparel, technology and, let's not forget, a good bit of gold thanks to the gold medal he carries with him in his pocket.
In his "Homework" segment, Cramer followed up on a few stocks that stumped him during earlier shows. He said Gaslog (GLOG) - Get Report is not for him because capacity in the tanker business is on the rise. Cramer did bless owning Interactive Intelligence (ININ) , but only as a speculative trade for investors willing to take big risks.
In his "Mad Tweets" segment, Cramer responded to questions sent via Twitter to @JimCramer.
Cramer said that if given the choice among Boulder Brands (BDBD) , WhiteWave Food (WWAV) and B&G Foods (BGS) - Get Report, he'd choose WhiteWave. Cramer also said that for the first time since the show began he likes both Sysco (SYY) - Get Report and Cisco Systems.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
-- Written by Scott Rutt in Washington, D.C.
To email Scott about this article, click here: Scott Rutt
At the time of publication, Cramer's Action Alerts PLUS had a position in AAPL and NKE.